Methyl 3,3,3-trifluoroalaninate hydrochloride, 95.0%, 5g

Fmoc-Asparatimol(OtBu), 95%, 10g

tert-Butyl chlorosulfonylcarbamate compound with 1,4-diazabicyclo[2.2.2]octane (1:2), 98%, 1g

Methyl 4-amino-5-bromo-2-fluorobenzoate, 95%, 100mg

Potassium ethoxide, 95.0%, 25g

(3aR,3'aR,8aS,8'aS)-2,2'-Ethylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 97%, 1g

Ethyl 5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 97%, 5g

METHYL 3-(METHYLAMINO)PROPANOATE HCL, 95.0%, 5g

(S)-methyl 5-((S)-1,1-dimethylethylsulfinamido)-5-(4-morpholinophenyl)-3-oxo-5-(thiophen-3-yl)pentanoate, 97%, 5mg

2-Nitrophenyl beta-D-Galactopyranoside [Substrate for beta-D-Galactosidase]>98.0%(HPLC)25g

(3-Bromo-4-chlorophenyl)hydrazine, 98%, 2.5g

Methyl 2-amino-5-(trifluoromethyl)benzoate, 98.0%, 100g

(S)-2-Amino-N-((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxopropan-2-yl)-3-methylbutanamide, 97%, 100mg